Validation of Heart Failure-Specific Risk Equations in 1.3 Million Israeli Adults and Usefulness of Combining

Sadiya S Khan1, Noam Barda2, Philip Greenland3

  • 1Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Insights

Heart failure risk prediction equations accurately identify at-risk individuals. The Pooled Cohort Equations to Prevent Heart Failure (PCP-HF) model shows strong performance in a large, real-world Israeli dataset, aiding in global HF prevention efforts.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Rising global heart failure (HF) prevalence necessitates effective prevention strategies.
  • Current HF risk prediction models often lack validation in diverse, real-world populations outside the US.
  • Accurate risk assessment is crucial for targeted HF prevention interventions.

Purpose of the Study:

  • To externally validate the performance of the Pooled Cohort Equations to Prevent Heart Failure (PCP-HF) for 5- and 10-year risk prediction.
  • To assess the PCP-HF model's accuracy in a large, contemporary Israeli cohort using electronic health records.
  • To evaluate the utility of these equations for predicting incident HF in a non-US population.

Main Methods:

  • Retrospective cohort study of 1,394,411 Israeli residents (2008-2018).
  • Utilized electronic health records to extract demographics and risk factors (BMI, BP, glucose, medications, smoking).
  • Applied PCP-HF equations to estimate 5- and 10-year HF risk and assessed model discrimination (C-statistic).

Main Results:

  • The PCP-HF model demonstrated excellent discrimination for 5-year (C-statistic=0.82) and 10-year (C-statistic=0.84) incident HF prediction.
  • Incident HF occurred in 1.2% of participants over 5 years and 4.5% over 10 years.
  • The model performed well across a large, diverse patient population.

Conclusions:

  • The PCP-HF risk prediction equations are accurate and reliable for estimating 5- and 10-year HF risk in a non-US population.
  • These validated equations can be effectively used with routinely collected clinical data for HF risk stratification.
  • The findings support the broader application of PCP-HF for global heart failure prevention efforts.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
67
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
114
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
95
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
78
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
43